Sunitinib-Induced Acute Interstitial Nephritis in a Thrombocytopenic Renal Cell Cancer Patient

Sunitinib, a multitargeted tyrosine kinase inhibitor (TKI), is currently the standard of care for patients with metastatic renal cell carcinoma. Renal adverse events associated with sunitinib include proteinuria, renal insufficiency secondary to focal segmental glomerulosclerosis (FSGS), and thrombo...

Descripción completa

Detalles Bibliográficos
Autores principales: Azar, Ibrahim, Esfandiarifard, Saghi, Sinai, Pedram, Wazir, Ali, Foulke, Llewellyn, Mehdi, Syed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735624/
https://www.ncbi.nlm.nih.gov/pubmed/29359059
http://dx.doi.org/10.1155/2017/6328204

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735624/
https://www.ncbi.nlm.nih.gov/pubmed/29359059
http://dx.doi.org/10.1155/2017/6328204

Ejemplares similares